This study is in progress, not accepting new patients
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
a study on Inflammatory Bowel Disease
Ulcerative Colitis Colitis Colitis, Ulcerative Ulcer RPC1063 RPC0163 (Ozanimod)
Lead Scientist at UCSF
- Jonathan Terdiman
Dr. Jonathan P. Terdiman is a Professor of Clinical Medicine and Surgery and the Chief of the Gastroenterology Division at UCSF. He earned his undergraduate degree from Princeton University in 1985 and his medical degree from the Columbia University College of Physicians and Surgeons in 1989.